Correlation Between Pharmacokinetics and Pharmacologic Effects of a New Imidazole Thromboxane Synthetase Inhibitor

This publication has 21 references indexed in Scilit:

• Effects of γ-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function
  Thrombosis Research, 1986
• Selective and nonselective inhibition of thromboxane formation
  Clinical Pharmacology & Therapeutics, 1984
• The Effects of a New Thromboxane Synthetase Inhibitor, CGS‐13080, in Man
  The Journal of Clinical Pharmacology, 1984
• SELECTIVE INHIBITION OF THROMBOXANE SYNTHETASE BY DAZOXIBEN INCREASES PROSTACYCLIN PRODUCTION BY LEUCOCYTES IN ANGINA PATIENTS AND HEALTHY VOLUNTEERS
  The Lancet, 1982
• A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2
  Thrombosis Research, 1982
• THROMBOXANE SYNTHETASE INHIBITION AS ANTITHROMBOTIC STRATEGY
  The Lancet, 1981
• ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASE
  The Lancet, 1981
• Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarine
  Clinical Pharmacology & Therapeutics, 1979
• Aspirin and Thromboembolism — A Possible Dilemma
  New England Journal of Medicine, 1977
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976